Showing results (1-10 of 384) with videos related to

Sort By:
Pageof 39
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individualsNaa Torshie Annan, Mark Nelson, Sundhiya Mandalia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
The evolution of coreceptor tropism in HIV-infected patients interrupting suppressive antiretroviral therapyLaura J Waters, Andrew T Scourfield, Marie Marcano, et al.
Expert Opinion on Pharmacotherapy|March 25, 2006
Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patientsBrian G Gazzard
Pharmacogenomics|December 26, 2006
Oncology and pharmacogenetics in 2007Justin Stebbing
The Medico-Legal Journal|June 11, 2014
Cancer: Where were we, where are we, where are we goingJustin Stebbing
Journal of HIV Therapy|July 9, 2004
Does atazanavir cause lipodystrophy?Brian G Gazzard, Graeme Moyle
The Lancet. Oncology|July 10, 2003
What can oncologists learn from HIV?Justin Stebbing, Mark Bower
The Lancet. Oncology|January 4, 2006
Comparative pharmacogenomics of antiretroviral and cytotoxic treatmentsJustin Stebbing, Mark Bower
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2017
Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic VariationLars Soraas, Justin Stebbing
Anticancer Research|April 3, 2014
Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practicePanagiotis Papanastasopoulos, Justin Stebbing
Pageof 39